1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerDigestive System Diseases, Digestive System Neoplasms, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Liver Neoplasms, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, adenocarcinoma, astrocytoma (excluding glioblastoma), brain disorder, brainstem cancer, carcinoma, central nervous system cancer, central nervous system disorder, connective tissue neoplasm, diffuse intrinsic pontine glioma, ependymoma, epithelial neoplasm, fibrolamellar hepatocellular carcinoma, glioblastoma, glioma, hepatoblastoma, hepatocellular carcinoma, immune system disorder, immunoproliferative disorder, liver disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, melanocytic neoplasm, melanoma, mixed neoplasm, myomatous neoplasm, neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroepithelial neoplasm, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma, skin disorder, skin neoplasmActive, not recruitingPhase 1 / Phase 22025-11-12NCT06521567